<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01033383</url>
  </required_header>
  <id_info>
    <org_study_id>0908005581</org_study_id>
    <secondary_id>K23AG028691-01A2</secondary_id>
    <secondary_id>UL1RR024139</secondary_id>
    <secondary_id>KL2RR024138</secondary_id>
    <nct_id>NCT01033383</nct_id>
  </id_info>
  <brief_title>Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents</brief_title>
  <official_title>Pilot Study: Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate whether there is a particular dose of cranberry capsules that is
      effective in preventing the occurrence of urinary tract infections in females at least 65
      years of age or older who live in a nursing home and who have a history of urinary tract
      infections. The Yale research team will be enrolling 80 subjects in total over several
      nursing home locations within Connecticut.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each subject was enrolled after providing a baseline urine specimen. Cranberry/placebo
      capsules were consumed for 30 days. Urine specimens were obtained weekly for 4 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>E.Coli Bacteriuria Plus Pyuria</measure>
    <time_frame>One month</time_frame>
    <description>The number of urine cultures and urinalyses (obtained weekly) found with &gt;100,000 CFU/ml growth of E.coli and &gt;10 WBC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Other Bacteriuria Plus Pyuria</measure>
    <time_frame>one month</time_frame>
    <description>The number of urine cultures and urinalyses (obtained weekly) found with other bacteriuria plus any white blood cells (WBCs) &gt;100,000 colony that include: Proteus, Klebsiella, Enterococcus, beta-hemolytic Streptococci, viridans Streptococci, and organella morganii, Citrobacter freundii, and coagulase-negative Staphylococcus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Not Growth</measure>
    <time_frame>one month</time_frame>
    <description>The number of not growth, these include no growth, growth &lt;100,000 CFU/ml, growth &gt;100,000 CFU/ml but no WBCs, and mixed flora.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Bacteriuria</condition>
  <arm_group>
    <arm_group_label>3 placebo capsules</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3 placebo capsules qd</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1 cranberry capsule &amp; 2 placebo capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 active cranberry capsule and 2 placebo capsules qd</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 cranberry capsules &amp; 1 placebo capsule</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 active cranberry capsules and 1 placebo capsules qd</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 cranberry capsules</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 active cranberry capsules qd</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>36 milligram (mg) placebo capsule taken before quiet hours of sleep (qhs).</description>
    <arm_group_label>3 placebo capsules</arm_group_label>
    <arm_group_label>1 cranberry capsule &amp; 2 placebo capsules</arm_group_label>
    <arm_group_label>2 cranberry capsules &amp; 1 placebo capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cranberry Capsule</intervention_name>
    <description>36 milligram (mg) cranberry capsule, taken before quiet hours of sleep (qhs).</description>
    <arm_group_label>1 cranberry capsule &amp; 2 placebo capsules</arm_group_label>
    <arm_group_label>2 cranberry capsules &amp; 1 placebo capsule</arm_group_label>
    <arm_group_label>3 cranberry capsules</arm_group_label>
    <other_name>Ellura</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female nursing home residents 65 years of age or older with history of urinary tract
             infection within the past year.

        Exclusion Criteria:

          -  residents that are not expected to be in the nursing home for at least one month
             (i.e., short term rehabilitation, pending discharge, terminal [life expectancy &lt; 1
             month]);

          -  residents who are on chronic suppressive antibiotic or anti-infective (i.e.,
             mandelamine) therapy for recurrent UTI;

          -  residents with end stage renal disease on dialysis (they do not regularly produce
             urine);

          -  residents unable to produce a baseline clean catch urine specimen for collection;

          -  residents on warfarin therapy because of a potential interaction of warfarin and
             cranberry juice;

          -  residents with a history of nephrolithiasis because cranberry may increase the risk of
             nephrolithiasis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manisha Juthani-Mehta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northbridge Health Care Center</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sheriden Woods Health Care Center</name>
      <address>
        <city>Bristol</city>
        <state>Connecticut</state>
        <zip>06010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Carolton Chronic and Convalescent Hospital</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <zip>06824</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glastonbury Health Care Center</name>
      <address>
        <city>Glastonbury</city>
        <state>Connecticut</state>
        <zip>06033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlesex Health Care Center</name>
      <address>
        <city>Middletown</city>
        <state>Connecticut</state>
        <zip>06457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wadsworth Glen Health Care and Rehabilitation Center</name>
      <address>
        <city>Middletown</city>
        <state>Connecticut</state>
        <zip>06457</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beacon Brook Health Care Center</name>
      <address>
        <city>Naugatuck</city>
        <state>Connecticut</state>
        <zip>06770</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laurel Ridge Health Care Center</name>
      <address>
        <city>Ridgefield</city>
        <state>Connecticut</state>
        <zip>06877</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shady Knoll Health Center</name>
      <address>
        <city>Seymour</city>
        <state>Connecticut</state>
        <zip>06483</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Litchfield Woods Health Care Center</name>
      <address>
        <city>Torrington</city>
        <state>Connecticut</state>
        <zip>06790</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maefair Health Care Center</name>
      <address>
        <city>Trumbull</city>
        <state>Connecticut</state>
        <zip>06111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Masonicare Health Center</name>
      <address>
        <city>Wallingford</city>
        <state>Connecticut</state>
        <zip>06492</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Abbott Terracee Health Center</name>
      <address>
        <city>Waterbury</city>
        <state>Connecticut</state>
        <zip>06702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary Home</name>
      <address>
        <city>West Hartford</city>
        <state>Connecticut</state>
        <zip>06117</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bianco L, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. J Am Geriatr Soc. 2012 Jun;60(6):1180-1. doi: 10.1111/j.1532-5415.2012.03976.x.</citation>
    <PMID>22690994</PMID>
  </results_reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2009</study_first_submitted>
  <study_first_submitted_qc>December 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2009</study_first_posted>
  <results_first_submitted>March 19, 2013</results_first_submitted>
  <results_first_submitted_qc>July 12, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 15, 2013</results_first_posted>
  <last_update_submitted>July 12, 2013</last_update_submitted>
  <last_update_submitted_qc>July 12, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteriuria</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment of participants occurred at 11 nursing homes from December 2009 to December 2010.</recruitment_details>
      <pre_assignment_details>Once participants consented, they needed to be able to provide a clean catch urine specimen in order to be enrolled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>3 Placebo Capsules</title>
          <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
        </group>
        <group group_id="P2">
          <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
          <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
        </group>
        <group group_id="P3">
          <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
          <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
        </group>
        <group group_id="P4">
          <title>3 Cranberry Capsules</title>
          <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>3 Placebo Capsules</title>
          <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
        </group>
        <group group_id="B2">
          <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
          <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
        </group>
        <group group_id="B3">
          <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
          <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
        </group>
        <group group_id="B4">
          <title>3 Cranberry Capsules</title>
          <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="20"/>
            <count group_id="B5" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="88.8" spread="8"/>
                    <measurement group_id="B2" value="88.4" spread="7"/>
                    <measurement group_id="B3" value="88.8" spread="5"/>
                    <measurement group_id="B4" value="90.4" spread="7"/>
                    <measurement group_id="B5" value="89.1" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>E.Coli Bacteriuria Plus Pyuria</title>
        <description>The number of urine cultures and urinalyses (obtained weekly) found with &gt;100,000 CFU/ml growth of E.coli and &gt;10 WBC.</description>
        <time_frame>One month</time_frame>
        <population>The analysis population were those with completed labs data.</population>
        <group_list>
          <group group_id="O1">
            <title>3 Placebo Capsules</title>
            <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
          </group>
          <group group_id="O2">
            <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
            <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
          </group>
          <group group_id="O3">
            <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
            <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
          </group>
          <group group_id="O4">
            <title>3 Cranberry Capsules</title>
            <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
          </group>
        </group_list>
        <measure>
          <title>E.Coli Bacteriuria Plus Pyuria</title>
          <description>The number of urine cultures and urinalyses (obtained weekly) found with &gt;100,000 CFU/ml growth of E.coli and &gt;10 WBC.</description>
          <population>The analysis population were those with completed labs data.</population>
          <units>urine cultures and urinalyses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Urine cultures and urinalyses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Other Bacteriuria Plus Pyuria</title>
        <description>The number of urine cultures and urinalyses (obtained weekly) found with other bacteriuria plus any white blood cells (WBCs) &gt;100,000 colony that include: Proteus, Klebsiella, Enterococcus, beta-hemolytic Streptococci, viridans Streptococci, and organella morganii, Citrobacter freundii, and coagulase-negative Staphylococcus.</description>
        <time_frame>one month</time_frame>
        <population>The analysis population were those with completed labs data.</population>
        <group_list>
          <group group_id="O1">
            <title>3 Placebo Capsules</title>
            <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
          </group>
          <group group_id="O2">
            <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
            <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
          </group>
          <group group_id="O3">
            <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
            <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
          </group>
          <group group_id="O4">
            <title>3 Cranberry Capsules</title>
            <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
          </group>
        </group_list>
        <measure>
          <title>Other Bacteriuria Plus Pyuria</title>
          <description>The number of urine cultures and urinalyses (obtained weekly) found with other bacteriuria plus any white blood cells (WBCs) &gt;100,000 colony that include: Proteus, Klebsiella, Enterococcus, beta-hemolytic Streptococci, viridans Streptococci, and organella morganii, Citrobacter freundii, and coagulase-negative Staphylococcus.</description>
          <population>The analysis population were those with completed labs data.</population>
          <units>urine cultures and urinalyses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Urine cultures and urinalyses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Not Growth</title>
        <description>The number of not growth, these include no growth, growth &lt;100,000 CFU/ml, growth &gt;100,000 CFU/ml but no WBCs, and mixed flora.</description>
        <time_frame>one month</time_frame>
        <population>The analysis population were those with completed labs data.</population>
        <group_list>
          <group group_id="O1">
            <title>3 Placebo Capsules</title>
            <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
          </group>
          <group group_id="O2">
            <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
            <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
          </group>
          <group group_id="O3">
            <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
            <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
          </group>
          <group group_id="O4">
            <title>3 Cranberry Capsules</title>
            <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
          </group>
        </group_list>
        <measure>
          <title>Not Growth</title>
          <description>The number of not growth, these include no growth, growth &lt;100,000 CFU/ml, growth &gt;100,000 CFU/ml but no WBCs, and mixed flora.</description>
          <population>The analysis population were those with completed labs data.</population>
          <units>urine cultures and urinalyses</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="20"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Urine cultures and urinalyses</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="44"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>3 Placebo Capsules</title>
          <description>3 placebo capsules qd
Placebo : Three placebo capsules, each 36mg, qhs</description>
        </group>
        <group group_id="E2">
          <title>1 Cranberry Capsule &amp; 2 Placebo Capsules</title>
          <description>1 active cranberry capsule and 2 placebo capsules qd
1 cranberry capsule &amp; 2 placebo capsules : 1 36mg cranberry capsule, 2 36mg placebo capsules, all qhs</description>
        </group>
        <group group_id="E3">
          <title>2 Cranberry Capsules &amp; 1 Placebo Capsule</title>
          <description>2 active cranberry capsules and 1 placebo capsule qd
2 cranberry capsules &amp; 1 placebo capsule : 2 36mg cranberry capsules, 1 placebo capsule, all qhs</description>
        </group>
        <group group_id="E4">
          <title>3 Cranberry Capsules</title>
          <description>3 active cranberry capsules qd
3 cranberry capsules : 3 36mg cranberry capsules qhs</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Of 320 urine specimens that should have been collected by nursing staff, 302 (94%) urine cultures and 294 (92%) urinalyses were obtained.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Manisha Juthani-Mehta</name_or_title>
      <organization>Yale University</organization>
      <phone>(203)785-7571</phone>
      <email>manisha.juthani@yale.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

